Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/AF7E72AB.svg?ark=w1%2F20260515%2FAF7E72AB)](https://nobleid.org/work/w1/20260515/AF7E72AB)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors